Spectrophotometric methods for simultaneous estimation of rabeprazole sodium and aceclofenac from the combined capsule dosage form

Sri Venkatesh U; Divya Suggu

doi:10.47957/ijpda.v13i3.648

Authors

U Sri Venkatesh Sri Sivani College of Pharmacy, Chilakapalem, Srikakulam.
Suggu Divya Sri Sivani College of Pharmacy, Chilakapalem, Srikakulam.

DOI:

https://doi.org/10.47957/ijpda.v13i3.648

Keywords:

Aceclofenac, absorbance ratio method, rabeprazole sodium, simultaneous equation method, spectrometric estimation

Abstract

Introduction: The present work aimed to develop and validate spectrophotometric methods for simultaneous estimation of rabeprazole sodium and aceclofenac in a pure and capsule dosage form.

Materials and Methods: Method 1 is based on solving a simultaneous equation. Absorbances of rabeprazole sodium and aceclofenac were measured at their respective absorbance maximas (?max) of 283 and 276 nm. Method 2 is the Q-analysis or absorption ratio method. Absorbances were measured at 256 nm (isosbestic point) and 276 nm (?max of aceclofenac). Methods are validated according to ICH guidelines.

Results: A linearity range for rabeprazole sodium and aceclofenac is 10–60 µg/ml at respective selected wavelengths. The coefficient of correlation for rabeprazole at 283 nm and for aceclofenac at 276 nm is 0.9981 and 0.9997, respectively. A percentage estimation of rabeprazole sodium and aceclofenac from the capsule dosage form by method 1 is 100.22 and 99.96 and by method 2 is 99.99 and 100.05, respectively, with a standard deviation less than 2.

Conclusion: The proposed methods are simple, rapid, and validated and can be used successfully for routine simultaneous estimation of rabeprazole sodium and aceclofenac in a pure and capsule dosage form.

Downloads

Download data is not yet available.

References

Rohit S, Chandrakant M, Shital KP, Dhanya K, Nilofar N. Validated spectroscopic method for estimation of aceclofenac from tablet. Res J Pharm Tech 2008;1:430-2

Maheshwari RK, Chaturvedi SC, Jain NK. Analysis of aceclofenac in tablets using hydrotropic solublisation technique. Indian Drugs 2006;43:516-8.

Mallikarjuna GM, Somashekar S, Putta RK, Shanta SM. Physico- chemical characterization, UV spectrophotometric analytical method development and validation studies of rabeprazole sodium. J Chem Pharm Res 2010;2:187-92.

Nafisur RZ, Syed NH. Quantitative analysis of rabeprazole sodium in commercial dosage forms by spectrophotometry. Chem Pharm Bull 2008;56:995-1001.

Lohe RW, Suruse PB, Kale MK, Barethiya PR, Kasture AV, Lohe SW. Spectrophotometric methods for simultaneous estimation of rabeprazole and diclofenac from combined tablet dosage form. Asian J Res Chem 2008;1:26-8.

Shaik HR, Arieaf M, Sandhya VP, Silpa RG, Venkateswarlu G. Simultaneous estimation of rabeprazole sodium and Itopride hydrochloride in capsule dosage form by uv spectrophotometry. Res J Pharm Tech 2011;4:558-56.

Sujata JG, Mrunalini MD, Mahajan MP. Simultaneous estimation of tizanidine and aceclofenac in bulk drug and tablet formulation by q-analysis and area under curve. Int J Pharm Sci Rev Res 2011;8:58-61.

Bhure MV, Hemke AT, Gupta KR. UV-Spectrophotometric methods for determination of aceclofenac and diacerein in pharmaceutical formulation. J Pharm Sci Res 2010;2:426-32.

Beckett AK, Stanlake JB. Practical Pharmaceutical Chemistry. 4th ed,

Part II. New Delhi: CBS Publishers; 1997. p. 286-8.

ICH, Q2A Text on validation of analytical procedures: Methodology International Conference on Harmonization of technical requirements for registration of pharmaceutical for human use, Geneva, Switzerland; 1996.